Queen's health researchers receive $8 million
Researchers studying eye movement in brain function, urinary incontinence, malignant melanoma and chemotherapy for lung cancer are among 13 Queen’s University projects receiving $8 million this year from the Canadian Institutes of Health Research (CIHR).
Queen’s recipients include:
• John Allingham (Biochemistry), who receives $621, 710 to study “Structural and functional analyses of novel heterodimeric kinesin motors”
• Alastair Ferguson (Physiology) receives $784,562 towards “Circumventricular Organs - New CNS sites for the Regulation of Energy Homeostasis”
• Patti Groome (Community Health and Epidemiology) receives $92,645 towards “Diagnostic delay in oral cavity cancer”
• Zongchao Jia (Biochemistry) receives $848,640 towards “Emerging structural insights into prokaryotic phosphorylation systems”
• Michael Kawaja (Anatomy and Cell Biology) receives $718,324 towards “Mechanisms underlying sympathetic sprouting in sensory ganglia after nerve injury”
• Linda McLean (School of Rehabilitation Therapy) receives $213,995 towards “Biomechanical assessment of the female continence mechanism in women with and without stress urinary incontinence”
• Doug Munoz (Physiology) receives $953,386 towards “Using eye movements to probe brain function and dysfunction in humans”
• Michael Nesheim (Biochemistry) receives $619,484 towards “Functional Properties of Prothrombinase”
Funding recipients with affiliations to both Queen’s and Kingston General Hospital are:
• Chris Booth (Oncology and Medicine) who receives $321,950 towards “Adoption of Adjuvant Chemotherapy for Non-Small Cell Lung Cancer in Ontario: A Population-Based Outcomes Study”
• Roger Deeley (Oncology and Pathology & Molecular Medicine) receives $980,680 towards “MRP Mediated Multidrug Resistance ”
• David Lillicrap (Pathology & Molecular Medicine) receives $933,023 towards “Molecular studies of von Willebrand factor pathobiology.”
• Will Pickett (Community Health and Epidemiology) receives $571,991 towards “Built environments as determinants of health in young Canadians, and the role of social environments as intermediary factors”
• Victor Tron ((Pathology and Molecular Medicine) receives $397, 897 towards “The role of microRNAs in Malignant Melanoma”
This research will be carried out over the next one to five years.
The CIHR is the Government of Canada's agency for health research. Its mission is to create new scientific knowledge and to catalyze its translation into improved health, more effective health services and products, and a strengthened Canadian health care system. www.cihr-irsc.gc.ca/
Attention broadcasters: Queen’s has facilities to provide broadcast quality audio and video feeds. For television interviews, we can provide a live, real-time double ender from Kingston fibre optic cable. Please call for details.